Show simple item record

dc.contributor.authorWorld Health Assembly, 53
dc.coverage.spatialGenevaen
dc.date.accessioned2013-04-03T15:23:33Z
dc.date.available2013-04-03T15:23:33Z
dc.date.issued2000
dc.identifier.govdocA53/10
dc.identifier.urihttp://www.who.int/iris/handle/10665/79026
dc.descriptionWorld Health Assembly fifty-third session, provisional agenda item 12.8en
dc.language.isoenen
dc.publisherWorld Health Organizationen
dc.subjectPharmaceutical productsen
dc.subject.meshPharmaceutical Preparationsen
dc.subject.meshOrganizational Objectivesen
dc.subject.meshDrug Delivery Systemsen
dc.subject.meshDrug Industryen
dc.subject.meshDrugs, Essentialen
dc.titleRevised drug strategy: report by the Secretariaten
dc.typeGoverning body documentsen
dc.subject.meshqualifierstandardsen


Files in this item

Thumbnail

This item appears in the following Collection(‎s)‎

Show simple item record